LF-rTMS also upregulates striatal dopamine D2-receptor expression, enhances dopaminergic signaling, and alleviates Parkinson’s disease-associated REM sleep behavior disorder (RBD) (Ahmed et al., 2012). This evidence concerns the gene DRD2 and Parkinson disease.